Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Antibody Therapeutics|January 23, 2023
Comparative Assessment of the Binding and Neutralisation Activity of Bispecific Antibodies Against SARS-CoV-2 VariantsAlexis Q Dean, Charles B Stauft, Julianne D Twomey, et al.Oncology Reports|August 30, 2017
MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathwayZehang Zhuang, Fengchun Hu, Jing Hu, et al.Msphere|June 16, 2021
SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers ProtectionIvette A Nuñez, Christopher Z Lien, Prabhuanand Selvaraj, et al.Plos One|May 17, 2018
Plasma membrane insertion of KCa2.3 (SK3) is dependent upon the SNARE proteins, syntaxin-4 and SNAP23Claudia A Bertuccio, Tony T Wang, Kirk L Hamilton, et al.International Journal of Molecular Sciences|January 8, 2023
HIF-1α-Dependent Metabolic Reprogramming, Oxidative Stress, and Bioenergetic Dysfunction in SARS-CoV-2-Infected HamstersSirsendu Jana, Michael R Heaven, Charles B Stauft, et al.Journal of Virology|March 9, 2021
The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13Shufeng Liu, Prabhuanand Selvaraj, Christopher Z Lien, et al.Biorxiv : the Preprint Server for Biology|April 6, 2021
SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunityIvette A Nuñez, Christopher Z Lien, Prabhuanand Selvaraj, et al.Journal of the American Chemical Society|July 17, 2019
Intercepted Retro-Nazarov Reaction: Syntheses of Amidino-Rocaglate Derivatives and Their Biological Evaluation as eIF4A InhibitorsWenhan Zhang, Jennifer Chu, Andrew M Cyr, et al.Microbiology Spectrum|January 28, 2025
Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikesSabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, et al.Ebiomedicine|February 13, 2016
A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf PathwayShufeng Liu, Wenyu Wang, Lauren E Brown, et al.Pageof 5